Volume 15 - Autumn,Winter                   RJMS 2009, 15 - Autumn,Winter: 115-120 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shaddel M, Ormazdi H, Akhlaghi L, Kazemi B, Bandepour M. Evaluating the Cloning of Leishmania Major p4 Gene in Production of Vaccine. RJMS 2009; 15 :115-120
URL: http://rjms.iums.ac.ir/article-1-1069-en.html
Abstract:   (8208 Views)

    Background and Aim: Leishmania major p4 gene is normally expressed during amastigote form of the parasite and can be a good candidate for producing an effective vaccine. The aim of this study is to clone p4 gene in a suitable vector for further vaccine production studies .

Materials and Methods: This is an experimental study. Leishmania promastigote was grown in N.N.N. medium and later in the form of mass culture in RPMI 1640 cell culture medium. Total leishmania genomic DNA was extracted by centrifugation of promastigote and lysed by lysis buffer followed by boiling method. PCR was carried out using p4 gene specific primers. PCR product was detected by agaros gel electrophoresis and cloned into Bluescript plasmid via T/A cloning method. After transformation, the recombinant plasmid was screened  and digested by restriction enzyme

Results: PCR reaction and cloning p4 gene in T-vector was done successfully. Recombinant plasmid was extracted and cloned gene was released by restriction enzyme and subcloned into pPQE-30 expression vector and confirmed by restriction analysis and PCR.

Conclusion: This newly expressed combination is p4 gene invitro. Production of p4 recombinant antigen is very much useful especially in the field of vaccine production, drug target and immunological studies.

Full-Text [PDF 224 kb]   (3136 Downloads)    
Type of Study: Research | Subject: parasitology

Add your comments about this article : Your username or Email:

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 CC BY-NC 4.0 | Razi Journal of Medical Sciences

Designed & Developed by : Yektaweb